TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
COCH

Envoy Medical Inc.

Healthcare · Medical Devices

0.6802$ -4.2% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Envoy Medical Inc. (COCH)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 49.8% of the shares are freely tradable; institutional investors hold 22.9%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 22.9%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 40.5%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 49.8%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 1.3%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 77Mio.

Largest Shareholders

Institutions

Institutions COCH
Name Stake (%) Shares Change (%) Date
Nantahala Capital Management, LLC 9.88 7,650,000 +0.0 03/31/2026
Bleichroeder LP 8.08 6,250,000 +0.0 03/31/2026
Vanguard Capital Management, LLC 1.14 881,672 +0.0 03/31/2026
Geode Capital Management, LLC 0.67 521,824 +430.6 03/31/2026
Vanguard Fiduciary Trust Co 0.38 294,721 +0.0 03/31/2026
The Colony Group LLC 0.27 212,655 +0.0 03/31/2026
Arcus Capital Partners LLC 0.24 187,573 +0.0 03/31/2026

Funds

Funds COCH
Name Stake (%) Shares Change (%) Date
Vanguard Institutional Extnd Mkt Idx Tr 0.78 606,649 +0.0 07/31/2026
Vanguard MStar Total Stk Mkt Idx Invest 0.35 273,565 +0.0 07/31/2026
Fidelity Extended Market Index 0.33 252,597 -0.2 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?